Filing Details

Accession Number:
0001209191-12-046535
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-24 17:25:42
Reporting Period:
2012-09-21
Filing Date:
2012-09-24
Accepted Time:
2012-09-24 17:25:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1435944 Lucy Shapiro C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-21 10,000 $6.30 387,416 No 4 S Indirect MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
Common Stock Disposition 2012-09-24 10,000 $6.35 377,416 No 4 S Indirect MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
No 4 S Indirect MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 36,248 Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2012.
  2. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.47, inclusive.
  3. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.29 to $6.58, inclusive.